Cargando…

Brain-derived neurotrophic factor protects serotonergic neurons against 3,4-methylenedioxymethamphetamine (“Ecstasy”) induced cytoskeletal damage

3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) use has been linked to persistent alterations of the brain serotonergic (5-HT) system in animal and human studies, but the molecular underpinnings are still unclear. Cytoskeletal structures such as neurofilament light chain (NfL) are promising mark...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bavato, F., Stamatakos, S., Ohki, C. M. Yde, Seifritz, E., Romualdi, P., Grünblatt, E., Quednow, B. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Vienna 2022
Materias:	Psychiatry and Preclinical Psychiatric Studies - Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188522/ https://www.ncbi.nlm.nih.gov/pubmed/35420371 http://dx.doi.org/10.1007/s00702-022-02502-8

Ejemplares similares

Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
por: Wunderli, Michael D, et al.
Publicado: (2017)

Growth rates of human induced pluripotent stem cells and neural stem cells from attention-deficit hyperactivity disorder patients: a preliminary study
por: Yde Ohki, Cristine Marie, et al.
Publicado: (2023)

A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)
por: Capela, João Paulo, et al.
Publicado: (2022)

Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy
por: Oeri, Hans Emanuel
Publicado: (2020)

Methylenedioxymethamphetamine (MDMA, ‘Ecstasy’): Neurodegeneration versus Neuromodulation
por: Puerta, Elena, et al.
Publicado: (2011)

Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use Is Related to Glutamate and GABA Concentrations in the Striatum But Not the Anterior Cingulate Cortex
por: Zimmermann, Josua, et al.
Publicado: (2023)

Autophagy Activation Is Involved in 3,4-Methylenedioxymethamphetamine (‘Ecstasy’)—Induced Neurotoxicity in Cultured Cortical Neurons
por: Li, I-Hsun, et al.
Publicado: (2014)

Additive Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Compassionate Imagery on Self-Compassion in Recreational Users of Ecstasy
por: Kamboj, Sunjeev K., et al.
Publicado: (2017)

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
por: Sessa, Ben, et al.
Publicado: (2019)

Extracorporeal Membrane Oxygenation Support in Refractory Multi-organ Failure by 3,4-Methylenedioxymethamphetamine Intoxication (“Ecstasy”)
por: Ruiz, Victoria, et al.
Publicado: (2022)

3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review
por: Inouye, Ann, et al.
Publicado: (2022)

Pentoxifylline Protects the Rat Liver Against Fibrosis and Apoptosis Induced by Acute Administration of 3,4-Methylenedioxymethamphetamine (MDMA or Ecstasy)
por: Movassaghi, Shabnam, et al.
Publicado: (2013)

Does ±3,4-methylenedioxymethamphetamine (ecstasy) induce subjective feelings of social connection in humans? A multilevel meta-analysis
por: Regan, Annie, et al.
Publicado: (2021)

Association study and a systematic meta-analysis of the VNTR polymorphism in the 3′-UTR of dopamine transporter gene and attention-deficit hyperactivity disorder
por: Grünblatt, Edna, et al.
Publicado: (2019)

The effect of 3,4- methylenedioxymethamphetamine on expression of neurotrophic factors in hippocampus of male rats
por: Soleimani Asl, Sara, et al.
Publicado: (2017)

Activation of Antioxidant and Proteolytic Pathways in the Nigrostriatal Dopaminergic System After 3,4-Methylenedioxymethamphetamine Administration: Sex-Related Differences
por: Costa, Giulia, et al.
Publicado: (2021)

Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): The Influence of Gender and Genetics (CYP2D6, COMT, 5-HTT)
por: Pardo-Lozano, Ricardo, et al.
Publicado: (2012)

Neuromorphological and functional effects of ecstasy during serotonergic damage and recovery
por: Kirilly, Eszter, et al.
Publicado: (2009)

3,4-Methylenedioxymethamphetamine facilitates fear extinction learning
por: Young, M B, et al.
Publicado: (2015)

3,4-methylenedioxymethamphetamine (MDMA): current perspectives
por: Meyer, Jerrold S
Publicado: (2013)

Therapeutic setting as an essential component of psychedelic research methodology: Reporting recommendations emerging from clinical trials of 3,4-methylenedioxymethamphetamine for post-traumatic stress disorder
por: Okano, Lauren, et al.
Publicado: (2022)

The impact of maternal care and blood glucose availability on the cortisol stress response in fasted women
por: Bentele, Ulrike U., et al.
Publicado: (2021)

Sweat it out? The effects of physical exercise on cognition and behavior in children and adults with ADHD: a systematic literature review
por: Den Heijer, Anne E., et al.
Publicado: (2016)

Assessment of psychiatric comorbidities and serotonergic or noradrenergic medication use on blood pressure using 24‐hour ambulatory blood pressure monitoring
por: Niazi, Shehzad K., et al.
Publicado: (2021)

Influence of stress on physiological synchrony in a stressful versus non-stressful group setting
por: Denk, Bernadette, et al.
Publicado: (2021)

The Nature of 3, 4-Methylenedioxymethamphetamine (MDMA)-Induced Serotonergic Dysfunction: Evidence for and Against the Neurodegeneration Hypothesis
por: Biezonski, Dominik K, et al.
Publicado: (2011)

The Non-Peptide Arginine-Vasopressin v(1a) Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish
por: Ponzoni, Luisa, et al.
Publicado: (2017)

Basic processes as foundations of cognitive impairment in adult ADHD
por: Butzbach, Marah, et al.
Publicado: (2019)

Feigning ADHD and stimulant misuse among Dutch university students
por: Fuermaier, Anselm B. M., et al.
Publicado: (2021)

Non-credible symptom report in the clinical evaluation of adult ADHD: development and initial validation of a new validity index embedded in the Conners’ adult ADHD rating scales
por: Becke, Miriam, et al.
Publicado: (2021)

ADHD at the workplace: ADHD symptoms, diagnostic status, and work-related functioning
por: Fuermaier, Anselm B. M., et al.
Publicado: (2021)

Metacognition in adult ADHD: subjective and objective perspectives on self-awareness of cognitive functioning
por: Butzbach, Marah, et al.
Publicado: (2021)

Financial judgment determination in adults with ADHD
por: Koerts, Janneke, et al.
Publicado: (2021)

Functional connectivity during cognitive control in children with autism spectrum disorder: an independent component analysis
por: Ambrosino, S., et al.
Publicado: (2014)

Multidimensional assessment of neuroendocrine and psychopathological profiles in maltreated youth
por: Puetz, Vanessa B., et al.
Publicado: (2016)

Public perceptions of adult ADHD: Indications of stigma?
por: Godfrey, Emmet, et al.
Publicado: (2020)

Neurological soft signs are increased in major depressive disorder irrespective of treatment
por: Schülke, Rasmus, et al.
Publicado: (2023)

Sustained attention in adult ADHD: time-on-task effects of various measures of attention
por: Tucha, Lara, et al.
Publicado: (2015)

Neuropsychological functioning of individuals at clinical evaluation of adult ADHD
por: Guo, Nana, et al.
Publicado: (2020)

Effects of 3,4-Methylenedioxymethamphetamine Administration on Retinal Physiology in the Rat
por: Martins, João, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ov4vmg5705s93km374p9jelm8e